Literature DB >> 16646631

Physical activity and high-sensitivity C-reactive protein.

Eric P Plaisance1, Peter W Grandjean.   

Abstract

Cardiovascular disease (CVD) remains one of the leading causes of death and disability in developed countries around the world despite the documented success of lifestyle and pharmacological interventions. This illustrates the multifactorial nature of atherosclerosis and the use of novel inflammatory markers as an adjunct to risk factor reduction strategies. As evidence continues to accumulate that inflammation is involved in all stages of the development and progression of atherosclerosis, markers of inflammation such as high-sensitivity C-reactive protein (CRP) may provide additional information regarding the biological status of the atherosclerotic lesion. Recent investigations suggest that physical activity reduces CRP levels. Higher levels of physical activity and cardiorespiratory fitness are consistently associated with 6-35% lower CRP levels. Longitudinal training studies that have demonstrated reductions in CRP concentrations range from 16% to 41%, an effect that may be independent of baseline levels of CRP, body composition or weight loss. The average change in CRP associated with physical activity appears to be at least as good, if not better, than currently prescribed pharmacological interventions in similar populations. The primary purpose of this review will be to present evidence from both cross-sectional and longitudinal investigations that physical activity lowers CRP levels in a dose-response manner. Finally, this review will examine factors such as body composition, sex, blood sample timing, diet and smoking, which may influence the CRP response to physical activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16646631     DOI: 10.2165/00007256-200636050-00006

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  105 in total

1.  Physical training reduces peripheral markers of inflammation in patients with chronic heart failure.

Authors:  S Adamopoulos; J Parissis; C Kroupis; M Georgiadis; D Karatzas; G Karavolias; K Koniavitou; A J Coats; D T Kremastinos
Journal:  Eur Heart J       Date:  2001-05       Impact factor: 29.983

2.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Authors:  P M Ridker; N Rifai; M Clearfield; J R Downs; S E Weis; J S Miles; A M Gotto
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

3.  Weight loss reduces C-reactive protein levels in obese postmenopausal women.

Authors:  André Tchernof; Amy Nolan; Cynthia K Sites; Philip A Ades; Eric T Poehlman
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

4.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.

Authors:  Katherine Esposito; Alessandro Pontillo; Carmen Di Palo; Giovanni Giugliano; Mariangela Masella; Raffaele Marfella; Dario Giugliano
Journal:  JAMA       Date:  2003-04-09       Impact factor: 56.272

5.  Exercise type and intensity in relation to coronary heart disease in men.

Authors:  Mihaela Tanasescu; Michael F Leitzmann; Eric B Rimm; Walter C Willett; Meir J Stampfer; Frank B Hu
Journal:  JAMA       Date:  2002 Oct 23-30       Impact factor: 56.272

6.  Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women.

Authors:  Simin Liu; JoAnn E Manson; Julie E Buring; Meir J Stampfer; Walter C Willett; Paul M Ridker
Journal:  Am J Clin Nutr       Date:  2002-03       Impact factor: 7.045

7.  Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease.

Authors:  J K Smith; R Dykes; J E Douglas; G Krishnaswamy; S Berk
Journal:  JAMA       Date:  1999-05-12       Impact factor: 56.272

8.  Physical activity, body fat, and serum C-reactive protein in postmenopausal women with and without hormone replacement.

Authors:  Patricia J Manns; Daniel P Williams; Christine M Snow; Rosemary C Wander
Journal:  Am J Hum Biol       Date:  2003 Jan-Feb       Impact factor: 1.937

9.  C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

Authors:  Sridevi Devaraj; Dan Yan Xu; Ishwarlal Jialal
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

10.  Can exercise training with weight loss lower serum C-reactive protein levels?

Authors:  Koichi Okita; Hirotaka Nishijima; Takeshi Murakami; Tatsuya Nagai; Noriteru Morita; Kazuya Yonezawa; Kenji Iizuka; Hideaki Kawaguchi; Akira Kitabatake
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-07-29       Impact factor: 8.311

View more
  64 in total

1.  Pentraxin3 and high-sensitive C-reactive protein are independent inflammatory markers released during high-intensity exercise.

Authors:  Toshiaki Nakajima; Miwa Kurano; Takaaki Hasegawa; Haruhito Takano; Haruko Iida; Tomohiro Yasuda; Taira Fukuda; Haruhiko Madarame; Kansei Uno; Kentaro Meguro; Taro Shiga; Mina Sagara; Taiji Nagata; Koji Maemura; Yasunobu Hirata; Tatsuya Yamasoba; Ryozo Nagai
Journal:  Eur J Appl Physiol       Date:  2010-07-17       Impact factor: 3.078

Review 2.  Effects of exercise on c-reactive protein in healthy patients and in patients with heart disease: A meta-analysis.

Authors:  Tracy L Hammonds; Emily C Gathright; Carly M Goldstein; Marc S Penn; Joel W Hughes
Journal:  Heart Lung       Date:  2016-02-23       Impact factor: 2.210

3.  Objectively measured physical activity and C-reactive protein: National Health and Nutrition Examination Survey 2003-2004.

Authors:  P Loprinzi; B Cardinal; C Crespo; G Brodowicz; R Andersen; E Sullivan; E Smit
Journal:  Scand J Med Sci Sports       Date:  2011-08-03       Impact factor: 4.221

4.  Inflammation as a cardiovascular risk factor and pulse wave velocity as a marker of early-stage atherosclerosis in the Japanese population.

Authors:  Yasuaki Saijo; Megumi Utsugi; Eiji Yoshioka; Tomonori Fukui; Fumihiro Sata; Naoki Nakagawa; Naoyuki Hasebe; Takahiko Yoshida; Reiko Kishi
Journal:  Environ Health Prev Med       Date:  2009-03-17       Impact factor: 3.674

5.  The association of C-reactive protein and physical activity among a church-based population of African Americans.

Authors:  Swann Arp Adams; Michael D Wirth; Samira Khan; E Angela Murphy; Sue P Heiney; Lisa C Davis; Briana Davis; Ruby F Drayton; Thomas G Hurley; Steven N Blair; James R Hébert
Journal:  Prev Med       Date:  2015-05-22       Impact factor: 4.018

6.  Replication and reproducibility issues in the relationship between C-reactive protein and depression: A systematic review and focused meta-analysis.

Authors:  Sarah R Horn; Madison M Long; Benjamin W Nelson; Nicholas B Allen; Philip A Fisher; Michelle L Byrne
Journal:  Brain Behav Immun       Date:  2018-06-19       Impact factor: 7.217

7.  Chronic exposure to biomass fuel smoke and markers of endothelial inflammation.

Authors:  M A Caravedo; P M Herrera; N Mongilardi; A de Ferrari; V G Davila-Roman; R H Gilman; R A Wise; C H Miele; J J Miranda; W Checkley
Journal:  Indoor Air       Date:  2015-11-26       Impact factor: 5.770

8.  Evidence for anti-inflammatory effects of exercise in CKD.

Authors:  João L Viana; George C Kosmadakis; Emma L Watson; Alan Bevington; John Feehally; Nicolette C Bishop; Alice C Smith
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

9.  The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease.

Authors:  Theresa M Beckie; Jason W Beckstead; Maureen W Groer
Journal:  J Cardiovasc Nurs       Date:  2010 Jan-Feb       Impact factor: 2.083

10.  To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers.

Authors:  Mary-Frances O'Connor; Julie E Bower; Hyong Jin Cho; J David Creswell; Stoyan Dimitrov; Mary E Hamby; Michael A Hoyt; Jennifer L Martin; Theodore F Robles; Erica K Sloan; Kamala S Thomas; Michael R Irwin
Journal:  Brain Behav Immun       Date:  2009-04-21       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.